NSI Life - DGC Krill 500
Natural health product licensed in Canada
- Licence holder
- Zone Vitalité Spa
- NPN or DIN-HM
- 80076230
- Status
- Active licence
- Licence date
- 20 March 2017
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de krill Source : Euphausia superba - en entier Potency : 500 microgrammes Esterified astaxanthin | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 45 milligramme Docosahexaenoic acid | 500 milligramme | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 210 milligramme Phospholipids | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 75 milligramme Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 150 milligramme Omega-3 Fatty acids | Not specified | Not calculated |
Non-medicinal ingredients
Glycérine, Gélatine, Ethylvanilline, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur with shellfish; if this occurs, discontinue use.
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80076230
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Huile de krill
Read the warning, when it applies and the studies cited
Krill Oil
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (HC 2009).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.